199 related articles for article (PubMed ID: 29236153)
1. Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic.
Krasselt M; Baerwald C; Seifert O
Z Rheumatol; 2018 Oct; 77(8):727-734. PubMed ID: 29236153
[TBL] [Abstract][Full Text] [Related]
2. Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic.
Krasselt M; Ivanov JP; Baerwald C; Seifert O
Rheumatol Int; 2017 Feb; 37(2):229-237. PubMed ID: 27878345
[TBL] [Abstract][Full Text] [Related]
3. Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus.
Lawson EF; Trupin L; Yelin EH; Yazdany J
Semin Arthritis Rheum; 2015 Jun; 44(6):666-71. PubMed ID: 25701500
[TBL] [Abstract][Full Text] [Related]
4. Vaccination coverage in systemic lupus erythematosus-a cross-sectional analysis of the German long-term study (LuLa cohort).
Chehab G; Richter JG; Brinks R; Fischer-Betz R; Winkler-Rohlfing B; Schneider M
Rheumatology (Oxford); 2018 Aug; 57(8):1439-1447. PubMed ID: 29757414
[TBL] [Abstract][Full Text] [Related]
5. A survey of systemic lupus erythematosus patients' attitudes toward influenza and pneumococcal vaccination in Southwest China.
Chen Y; Chen B; Shen X; Zhou A; Liang Y; Wang Y; Chen H
Front Public Health; 2022; 10():1018899. PubMed ID: 36605245
[TBL] [Abstract][Full Text] [Related]
6. Adult immunizations: update on recommendations.
Pham H; Geraci SA; Burton MJ;
Am J Med; 2011 Aug; 124(8):698-701. PubMed ID: 21658665
[TBL] [Abstract][Full Text] [Related]
7. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services.
Willis BC; Ndiaye SM; Hopkins DP; Shefer A;
MMWR Recomm Rep; 2005 Apr; 54(RR-5):1-11. PubMed ID: 15800472
[TBL] [Abstract][Full Text] [Related]
8. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.
Murdaca G; Orsi A; Spanò F; Puppo F; Durando P; Icardi G; Ansaldi F
Autoimmun Rev; 2014 Feb; 13(2):75-84. PubMed ID: 24044940
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis.
Pugès M; Biscay P; Barnetche T; Truchetet MÉ; Richez C; Seneschal J; Gensous N; Lazaro E; Duffau P
Rheumatology (Oxford); 2016 Sep; 55(9):1664-72. PubMed ID: 27160278
[TBL] [Abstract][Full Text] [Related]
10. [Vaccinations from the pulmonologist's point of view].
Forstner C; Pletz MW
Internist (Berl); 2015 Jul; 56(7):838-46. PubMed ID: 26059891
[TBL] [Abstract][Full Text] [Related]
11. Influenza and pneumococcal vaccination coverage in Latin American patients with systemic lupus erythematosus: a cross-sectional and comparative study.
Chiganer EH; Ochi BC; Lessa CF
Adv Rheumatol; 2021 Jul; 61(1):46. PubMed ID: 34238387
[TBL] [Abstract][Full Text] [Related]
12. Vaccination for influenza and pneumococcus in patients with gastrointestinal cancer or inflammatory bowel disease: A prospective cohort study of methods for improving coverage.
Sitte J; Frentiu E; Baumann C; Rousseau H; May T; Bronowicki JP; Peyrin-Biroulet L; Lopez A
Aliment Pharmacol Ther; 2019 Jan; 49(1):84-90. PubMed ID: 30485467
[TBL] [Abstract][Full Text] [Related]
13. Lupus and vaccinations.
Mathian A; Pha M; Amoura Z
Curr Opin Rheumatol; 2018 Sep; 30(5):465-470. PubMed ID: 29889693
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN).
Chevet B; Figueroa-Parra G; Yang JX; Hulshizer CA; Gunderson TM; Duong SQ; Putman MS; Barbour KE; Crowson CS; Duarte-García A
J Rheumatol; 2022 Nov; 49(11):1276-1282. PubMed ID: 35777817
[TBL] [Abstract][Full Text] [Related]
15. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
[TBL] [Abstract][Full Text] [Related]
17. Association of standing-order policies with vaccination rates in dialysis clinics: a US-based cross-sectional study.
Bond TC; Patel PR; Krisher J; Sauls L; Deane J; Strott K; Karp S; McClellan W
Am J Kidney Dis; 2009 Jul; 54(1):86-94. PubMed ID: 19346041
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of the use in adults of four vaccines: a population survey in Argentina].
Vizzotti C; Katz N; Stecher D; Aquino A; Juárez MDV; Urueña A
Medicina (B Aires); 2018; 78(2):76-82. PubMed ID: 29659355
[TBL] [Abstract][Full Text] [Related]
19. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
[TBL] [Abstract][Full Text] [Related]
20. Are younger COPD patients adequately vaccinated for influenza and pneumococcus?
Gogou E; Hatzoglou C; Zarogiannis SG; Siachpazidou D; Gerogianni I; Kotsiou OS; Varsamas C; Gourgoulianis KI
Respir Med; 2022 Nov; 203():106988. PubMed ID: 36162248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
